Ligand Pharmaceuticals Market Risk Adjusted Performance
| LGND Stock | | | USD 202.91 -8.57 -4.05% |
This technical indicator view for Market Risk Adjusted Performance organizes signals for Ligand Pharmaceuticals Incorporated and comparable instruments. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context. Ligand Pharmaceuticals has a market cap of 4.05 B, operating margin of 33.59%, ROE of 13.47%. See
Correlation Analysis for portfolio-level analysis. This suggests a position in Ligand Pharmaceuticals Incorporated within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
Ligand Pharmaceuticals Incorporated has current Market Risk Adjusted Performance of 0.2145.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.2145 | |
| ER[a] | = | Expected return on investing in Ligand Pharmaceuticals |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Ligand Pharmaceuticals Market Risk Adjusted Performance Peers Comparison
Ligand Market Risk Adjusted Performance Relative To Other Indicators
Ligand Pharmaceuticals Incorporated holds the
#3 position for market risk adjusted performance relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers with a Maximum Drawdown-to-Market Risk Adjusted Performance ratio near
56.99 . The Maximum Drawdown to Market Risk Adjusted Performance ratio for Ligand Pharmaceuticals Incorporated comes in at
56.99 Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.